Fully Immunocompetent Porcine Model of Complicated Skin and Soft Tissue Infection Caused by Carbapenem-Resistant Pseudomonas aeruginosa

Varování

Publikace nespadá pod Ústav výpočetní techniky, ale pod Lékařskou fakultu. Oficiální stránka publikace je na webu muni.cz.
Autoři

VACEK Lukáš LIPOVÝ Břetislav POLAŠTÍK KLEKNEROVÁ Dominika JEKLOVÁ Edita LIŠKOVÁ Lenka HOLOUBEK Jakub MATYSKOVÁ Dominika RŮŽIČKA Filip

Rok publikování 2025
Druh Konferenční abstrakty
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
Popis Carbapenem-resistant Pseudomonas aeruginosa (CRPA) poses a significant threat to patients, often resulting in life-threatening infections. With increasing antimicrobial resistance, novel therapeutic strategies are urgently needed. Although animal models are crucial for preclinical studies, limited data are available for porcine models, more specifically for CRPA complicated skin and soft tissue infections (cSSTI). The study presents a novel porcine model inducing and sustaining cSSTI caused by CRPA. Six fully immunocompetent pigs (120 wounds) were used to develop wound infection and evaluate the progression of cSSTI in the model. Full-thickness skin defects (5 × 5 cm) with fascial incisions were surgically performed to introduce cSSTI. CRPA clinical strain FF2 (producing VIM carbapenemase) was used for wound infection development. Microbiological and histopathological assessment was performed by processing the tissue biopsy samples. The model demonstrated bacterial loads of 107 CFU/gram of tissue and higher with extensive areas of bacterial cells within the wound tissue and on its surface. The cSSTI fully developed within three days and remained as such for 14?days post-infection. The histopathological evaluation confirmed the full development of cSSTI. The samples were characterized by significant tissue infiltration by inflammatory cells, with a predominance of polymorphonuclear cells and macrophages. This fully immunocompetent model of cSSTI caused by CRPA will serve in the development of novel therapeutical strategies (including antimicrobial peptides and enzymes, phage therapy, etc.) and corresponding preclinical studies. All immunological processes associated with the wound healing process (especially the inflammatory and proliferative phases) are preserved.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info